Investigational Drug May Treat Biliary Cancers, Study Suggests

Courtesy ScienceDaily  Wed, 04/16/2008 - 16:00

Researchers have shown that the investigational drug triphendiol causes cell death in pancreatic and bile duct cancer cell lines, slows tumor growth and sensitizes tumors to chemotherapy treatments.

Scientists assessed the potential of triphendiol as a treatment for pancreatic adenocarcinoma using three representative cell lines.


 

More related items

UAB study shows investigational drug may treat biliary cancers
Laboratory studies by University of Alabama at Birmingham researchers have shown that the investigational drug triphendiol causes cell death in...

Targeted Therapy Combination Overcomes Treatment Resistance In...
Combining two targeted therapies overcomes treatment resistance in liver cancer cell lines, new research shows. Liver cancer is resistant to many...

By Amplifying Cell Death Signals, Scientists Make Precancerous...
On the cellular level, death signals can actually be life saving -- by killing off abnormally dividing cells before they turn cancerous. Now,...

By amplifying cell death signals, scientists make precancerous...
(Rockefeller University) On the cellular level, death signals can actually be life saving -- by killing off abnormally dividing cells before they...

Biochemistry: Board Review Series
BRS Biochemistry embodies the popular BRS format of succinct outline review of content followed by approximately 500 USMLE-style questions with...

Uncertainty: Einstein, Heisenberg, Bohr, and the Struggle for...
Werner Heisenberg’s “uncertainty principle” challenged centuries of scientific understanding, placed him in direct opposition to Albert...

Einstein's Mistakes: The Human Failings of Genius
Fresh insights into aspects of Einstein we don't usually consider: his mistakes and the role they played in the discovery of his theories.Although...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
science-nature.marc8.com